Chris Lewis

Chris Lewis is the Vice President of GMP Quality for Umoja Biopharma. Prior to joining Umoja in 2021, Chris served in various Quality leadership roles at Amgen, Sandoz/Novartis, AstraZeneca Biologics, and AveXis/Novartis Gene Therapies, helping to bring life-changing clinical and commercial biologic, small molecule, and gene therapy products to patients and their families around the world. To enable the manufacture of these products, Chris has had the honor and privilege of supporting the startup of five separate cGMP manufacturing facilities, including the building of teams and organizations focused on establishing and maturing an effective quality culture and best serving one another to best serve patients together.

Outside of Umoja, Chris has a passion for supporting growth in the local biotechnology community, serving as the current President of the Mountain States PDA Chapter and as a Mentor in the Colorado BioScience Institute’s Mentor Program.

Chris holds a Bachelor of Science degree in Molecular, Cellular, and Developmental Biology from the University of Colorado Boulder.